Second Sight Medical Products
Second Sight CEO Robert Greenberg received the most memorable Valentine's day gift ever when he learned on February 14 that his professional labor of love, the Argus II retinal prosthesis system, had finally received FDA approval. A decade and a half in the making, the novel Argus II system restores sight to patients suffering from the degenerative disease retinitis pigmentosa. The bionic eye allows patients to see on a gray scale; however, the company is conducting color research and exploring image enhancement for future iterations. What started as a graduate school study years ago, over time, evolved into a truly groundbreaking, futuristic technology that earned the company the honor of being named MD+DI's 2013 Manufacturer of the Year.